Krystal Biotech Inc (KRYS) stock news · P/E 40, rev $389.1M
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
This KRYS news page leads with what Krystal Biotech Inc filed — not a scraped headline mill.
No cached 8-K sentence for KRYS yet. We will not pad this page with generic market recap.
Latest reported KRYS revenue for 2025-12-31 was $389.1M. Net income was $204.8M. Revenue was up 33.9% from 2024-12-31 to 2025-12-31. KRYS currently screens at market cap $10.17B and trailing P/E 39.7.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the KRYS stock page; for the tape open the quote page.
KRYS stock news FAQ
What are KRYS's latest revenue and net income?
Latest cached Krystal Biotech Inc (KRYS) revenue for Dec 31, 2025 was $389.1M. Net income was $204.8M. Statements: https://lician.com/financials/krys
How did KRYS revenue change from the prior cached period?
Cached Krystal Biotech Inc (KRYS) revenue was up 33.9% from $290.5M (Dec 31, 2024) to $389.1M (Dec 31, 2025). Statements: https://lician.com/financials/krys
What is KRYS's P/E ratio?
Krystal Biotech Inc (KRYS) trailing P/E is 39.7 on the latest cached fundamentals snapshot.
What is KRYS's market cap?
Krystal Biotech Inc (KRYS) market cap is $10.17B on the latest cached fundamentals snapshot.
What kind of company is KRYS?
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Where is KRYS stock news listed?
Cached stock news for Krystal Biotech Inc (KRYS) is listed at https://lician.com/news/krys. Filings: https://lician.com/sec/krys
Not investment advice.